Waltraut Maria Merz1, Rebecca Fischer-Betz, Kerstin Hellwig, Georg Lamprecht, Ulrich Gembruch. 1. Department of Obstetrics and Prenatal Medicine, Center for Obstetrics and Gynecology, University Hospital Bonn; Department of Rheumatology and Hiller, Forschungszentrum University Hospital Düsseldorf; Katholisches Klinikum Bochum, Neurology Clinic,Clinic of Ruhr-Universität Bochum; Department of Medicine II, Division of Gastroenterology and Endocrinology, University Medical Center Rostock; Department of Obstetrics and Prenatal Medicine, Center for Obstetrics and Gynecology, University Hospital Bonn.
Abstract
BACKGROUND: Pregnancies in women with chronic disease are on the rise. This pertains to autoimmune diseases in particular since these tend to affect women of childbearing age. The interaction between pregnancy and autoimmune disease may increase the risk of maternal, fetal, and obstetric complications; additional care may be required. METHODS: This review is based on a selective literature search in PubMed (2015-2020). RESULTS: In women with autoimmune diseases, the course of pregnancy is highly variable. Some autoimmune diseases tend to improve during pregnancy and do not to result in any serious obstetric complications. Others may worsen during pregnancy, with deterioration of the maternal condition as well as obstetric and perinatal complications. In systemic lupus erythematosus and myasthenia gravis, placental transfer of specific autoantibodies may cause fetal or neonatal disease. CONCLUSION: The care of pregnant women with chronic diseases requires collaboration between specialists of the pertinent levels of care. A stable course of disease before conception, close interdisciplinary care, and pregnancy-compatible medication contribute to a reduction in maternal and perinatal complications.
BACKGROUND: Pregnancies in women with chronic disease are on the rise. This pertains to autoimmune diseases in particular since these tend to affect women of childbearing age. The interaction between pregnancy and autoimmune disease may increase the risk of maternal, fetal, and obstetric complications; additional care may be required. METHODS: This review is based on a selective literature search in PubMed (2015-2020). RESULTS: In women with autoimmune diseases, the course of pregnancy is highly variable. Some autoimmune diseases tend to improve during pregnancy and do not to result in any serious obstetric complications. Others may worsen during pregnancy, with deterioration of the maternal condition as well as obstetric and perinatal complications. In systemic lupus erythematosus and myasthenia gravis, placental transfer of specific autoantibodies may cause fetal or neonatal disease. CONCLUSION: The care of pregnant women with chronic diseases requires collaboration between specialists of the pertinent levels of care. A stable course of disease before conception, close interdisciplinary care, and pregnancy-compatible medication contribute to a reduction in maternal and perinatal complications.
Authors: Marianne Wallenius; Kjell Å Salvesen; Anne K Daltveit; Johan F Skomsvoll Journal: Acta Obstet Gynecol Scand Date: 2014-01-28 Impact factor: 3.636
Authors: Edgar T Jaeggi; Jean-Claude Fouron; Earl D Silverman; Greg Ryan; Jeffrey Smallhorn; Lisa K Hornberger Journal: Circulation Date: 2004-09-07 Impact factor: 29.690
Authors: Peter M Izmirly; Amit Saxena; Sara K Sahl; Ummara Shah; Deborah M Friedman; Mimi Y Kim; Jill P Buyon Journal: Ann Rheum Dis Date: 2015-12-01 Impact factor: 19.103
Authors: Jill K Tjon; Gita M Tan-Sindhunata; Marianna Bugiani; Melinda M Witbreuk; Johannes A van der Sluijs; Marjan M Weiss; Laura A van de Pol; Mirjam M van Weissenbruch; Bloeme J van der Knoop; Johanna I de Vries Journal: Prenat Diagn Date: 2019-02-07 Impact factor: 3.050